Invention Grant
- Patent Title: Therapeutic uses of inhibitors of RTP801
- Patent Title (中): RTP801抑制剂的治疗用途
-
Application No.: US13601554Application Date: 2012-08-31
-
Publication No.: US08642571B2Publication Date: 2014-02-04
- Inventor: Elena Feinstein , Jorg Kaufmann , Klaus Giese
- Applicant: Elena Feinstein , Jorg Kaufmann , Klaus Giese
- Applicant Address: US CA Fremont
- Assignee: Quark Pharmaceuticals, Inc.
- Current Assignee: Quark Pharmaceuticals, Inc.
- Current Assignee Address: US CA Fremont
- Agency: Cooper & Dunham LLP
- Agent John P. White
- Priority: EP04019405 20040806
- Main IPC: C12N15/11
- IPC: C12N15/11 ; A61K48/00 ; C07H21/02 ; C07H21/04
Abstract:
The present invention provides novel molecules, compositions, methods and uses for treating microvascular disorders, eye diseases and respiratory conditions based upon inhibition of the RTP801 gene and/or protein.
Public/Granted literature
- US20130095117A1 THERAPEUTIC USES OF INHIBITORS OF RTP801 Public/Granted day:2013-04-18
Information query
IPC分类:
